MINNEAPOLIS--(BUSINESS WIRE)-- Medtronic, Inc. (NYSE: MDT) today announced the launch of Medtronic's first mobile application for use with implantable cardiac devices. As health care shifts care ...

FDA Approves New ICDs and CRT-Ds with Advanced Remote Capabilities DUBLIN, May 08, 2020 (GLOBE NEWSWIRE) -- Medtronic plc (NYSE:MDT) today announced results from late-breaking clinical trials ...

With the launch on Tuesday of its MyCareLink Heart mobile app, Medtronic has officially created the world’s first smartphone-connected pacemaker. The app pairs with Medtronic BlueSync pacemakers, and ...

Clinicians have been able to remotely monitor pacemakers for years thanks to a combination of near-field and remote wireless technologies, but until now, patients haven’t been able to access the data ...

Medtronic plcMDT recently reported receipt of the FDA approval for its MyCareLink Smart Monitor and subsequent commercial launch of the same in the U.S. Following the news on Nov 17, shares of the ...

Medtronic, Inc. announced the launch of its first mobile application for use with implantable cardiac devices. Medtronic’s technology is designed to give physicians greater flexibility in monitoring ...

Leading medical device player Medtronic plcMDT recently released favorable data on its app-based remote cardiac monitoring. The study, which was presented at the Heart Rhythm 2017, evaluated 5,595 ...

Now it's official: Smart devices can do everything. Medtronic ($MDT) has launched the first app-based remote monitoring for implantable pacemakers. Remote monitoring ...